The Use of Central Laboratories and Remote Electronic Data Capture to Risk-Adjust Therapy for Pediatric Acute Lymphoblastic Leukemia and Neuroblastoma
To access this article, please choose from the options below
PII: S0093-7754(09)00232-2
doi:10.1053/j.seminoncol.2009.12.007
© 2010 Elsevier Inc. All rights reserved.
